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Background: Gastroesophageal reflux disease (GERD) is the most common digestive disease, affecting one third of
the world’s population. The minimally invasive endoscopic Stretta procedure is being increasingly used as an
alternative strategy to manage refractory GERD. However, long-term benefits of this procedure have to be further
evaluated in clinical settings. This prospective observational study was therefore conducted to evaluate the
outcome of patients with refractory GERD 5 years after the Stretta procedure.
Methods: A total of 152 patients with refractory GERD underwent the Stretta procedure in our department
between April 2007 and September 2008. They were followed up for 5 years, during which the primary outcome
measures including symptom scores of heartburn, regurgitation, chest pain, cough and asthma and the secondary
outcome measures including proton pump inhibitor (PPI) use and patients’ satisfaction were analysed at 6, 12, 24,
36, 48 and 60 months respectively.
Results: Of the 152 patients, 138 completed the designated 5-year follow-up and were included in the final analysis.
At the end of the 5-year follow-up, the symptom scores of heartburn (2.47 ± 1.22 vs. 5.86 ± 1.52), regurgitation
(2.23 ± 1.30 vs. 5.56 ± 1.65), chest pain (2.31 ± 0.76 vs. 4.79 ± 1.59), cough (3.14 ± 1.43 vs. 6.62 ± 1.73) and asthma
(3.26 ± 1.53 vs. 6.83 ± 1.46) were all significantly decreased as compared with the corresponding values before the
procedure (P < 0.001). After the Stretta procedure, 59 (42.8%) patients achieved complete PPI therapy independence
and 104 (75.4%) patients were completely or partially satisfied with the GERD symptom control. Moreover, no severe
complications were observed except for complaint of abdominal distention in 12 (8.7%) patients after the Stretta
procedure.
Conclusion: The Stretta procedure may achieve an effective and satisfactory long-term symptom control and
considerably reduce the reliance on medication without significant adverse effects in adult patients with refractory
GERD, thereby having profound clinical implications.
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Gastroesophageal reflux disease (GERD) is the most com-
mon chronic digestive disorder in which the reflux of
gastric contents into the esophagus through the incompe-
tent lower esophageal sphincter (LES) causes troublesome
symptoms and/or complications [1]. Affecting one third of
the world’s population, GERD inflicts significant direct and
indirect costs and loss of productivity [2]. Apart from the
economic burden, GERD profoundly impacts the quality of
life of the affected individuals [3]. Currently, PPI-based
pharmacological therapy in combination with lifestyle
modifications (e.g., bed head elevation during sleep,
changes in dietary habits, restriction on alcohol consump-
tion, and body weight control) remains the mainstay of
GERD management [4,5]. As a class of potent gastric acid
secretion-inhibiting agents, PPIs are effective in most
GERD patients. However, PPI therapy involves an indefin-
itely prolonged or lifetime daily drug administration,
which is associated with significant adverse effects [6].
Moreover, up to 40% of GERD patients are refractory to
PPIs [7,8]. These intrinsic drawbacks of PPI therapy
necessitate the development of alternative strategies to
manage GERD.
With extensive efforts worldwide, several laparoscopic
and endoscopic modalities including various fundoplica-
tion techniques and the Stretta procedure that aim to cor-
rect the mechanical/physical defect underlying the gastric
content reflux have been invented in the past few decades
[9]. Although laparoscopic fundoplication, the 180-degree
laparoscopic anterior fundoplication in particular [10], may
achieve a satisfactory symptom relief and oesophagitis
healing without significant complications in selected indi-
viduals [11] and is now regarded as the “gold standard”
surgical management for refractory GERD [12], the wider
application of this approach is limited by its invasiveness,
high cost and inherent postoperative complications [13].
Accordingly, the Stretta procedure has been increasingly
used as the first-line therapy for selected patients with PPI-
refractory GERD [2,14], since its approval by the Food and
Drug Administration of the United States in 2000 [15].
The Stretta procedure is a minimally invasive endo-
scopic procedure that physically corrects the defect
underlying the gastric content reflux while irrigating the
overlying mucosa to prevent heat injury with radiofre-
quency energy delivered to the oesophageal wall and
LES complex through a flexible catheter with a balloon-
basket assembly and nickel-titanium needle electrodes
[16]. The efficacy, safety, and patients’ satisfaction of the
Stretta procedure have been evaluated in numerous
prospective and meta-analysis studies, mixed results
have been obtained [16-23]. This prospective observa-
tional study was therefore conducted to evaluate long-
term results of the Stretta procedure in selective adult
patients with PPI-refractory GERD.Methods
Ethical statement
This prospective observational study was approved by
the Institutional Review Board of the PLA’s Second
Artillery General Hospital in Beijing and conducted in
compliance with the ethical principles for medical
research involving human subjects stated in the World
Medical Association Declaration of Helsinki. Informed
consent was obtained from all subjects.
Subjects
A total of 152 patients with GERD, seeking care in the
Department of Gastroesophageal Reflux Disease in the
PLA’s Second Artillery General Hospital, Beijing, China,
were recruited consecutively between April, 2007 and
September, 2008. The inclusion criteria were: 1) GERD
diagnosed by endoscopically evidenced esophagitis or
abnormal oesophageal pH or DeMeester score ≥14.7 with
symptom correlation ≥50%, and/or reflux episodes >73
during a 24 h ambulatory impedance monitoring; 2) lower
than normal LES pressure detected by oesophageal man-
ometry; 3) endoscopically confirmed Los Angeles grade A
or B esophagitis; 4) non-hiatal hernia or small (<2 cm)
hiatal hernia; 5) absence of Barrett’s oesophagus; 6) signifi-
cantly impaired oesophageal motility; 7) persistent symp-
toms despite daily use of PPIs; and 8) age ≥18 years.
Patients who fulfilled the criteria were stratified as extrae-
sophageal symptoms and nonextraesophageal symptoms.
Patients with contradictions for surgery, severe dysphagia,
previous esophagogastric surgery, autoimmune disease,
collagen vascular disease, and/or coagulation disorders
were excluded.
Treatment
Stretta radiofrequency was performed on all patients as
previously described [24]. Briefly, the patient was sedated,
and the distance to the gastroesophageal junction was
measured under a gastroscope. Then the endoscope was
withdrawn and a radiofrequency-delivering catheter,
consisting of a flexible balloon-basket with four electrode
needle sheaths, was introduced orally using a guide wire.
The balloon was inflated 2 cm proximal to the squamo-
columnar junction, the electrode needles were deployed,
and radiofrequency energy was delivered for 1 min. The
needles were then withdrawn, the balloon was deflated
and the catheter was rotated 45°. These steps were serially
repeated every 0.5 cm inwards, covering an area 2 cm
above and 0.5 cm below the squamo-columnar junction.
Outcome assessment
The primary outcome measures of this study were the
frequency and severity of the major GERD symptoms
including heartburn, regurgitation, chest pain, cough
and asthma. Data on these outcome measures were
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6-point Likert scale system. More specifically, the
frequency was graded as 0 (none), 1 (less than once per
week), 2 (once or twice per week), 3 (three or four times
per week), 4 (five or six times per week) and 5 (more
than six times per week); the severity was graded as 0
(none), 1 (slight), 2 (mild), 3 (moderate), 4 (severe) and
5 (extremely severe). The total of the frequency score
and the severity score for each of these measures was
designated as the symptom score.
The secondary outcome measures were medication in-
dependence and patient satisfaction following the Stretta
procedure. Data on these measures were collected through
a questionnaire survey consisting of 2 questions: 1) are
you completely independent of PPIs; and 2) how are you
satisfied with the treatment (not all/partially/fully).
The questionnaires were prepared in simplified Chinese
and administered to the subjects before the Stretta
procedure and at 6, 12, 24, 36, 48 and 60-months post-
treatment on medications, respectively.
Statistical analysis
Data were expressed as mean ± standard deviation (SD)
unless specified otherwise. They were analysed by student
t test or nonparametric test based on their nature. The
statistical analysis software, SPSS-17.0 (SPSS Inc., Chicago,
IL, USA), was used. Differences were considered signifi-
cant when P < 0.05.
Results
Initially, 152 patients entered the study. During the desig-
nated 5-year follow-up, 12 patients dropped of the study
and 2 died of causes other than the Stretta procedure-
associated complications. As a result, 138 (91%) patients
had the complete follow-up data and were included in the
final analysis. Of these patients, 87 had extraesophageal
symptoms and 51 had no extraesophageal symptoms.
There was no significant difference either in the average
age (52.1 ± 13.0 vs. 52.1 ± 12.7, P = 0.94) or in male to
female ratio (35/87 vs. 24/51, P = 0.43) between extraeso-
phageal and non-extraesophageal symptom groups.
In the 138 patients included in the analysis, 94 (68.1%)
suffered from heartburn. The average total symptom score
for heartburn was 5.86 ± 1.52 prior to the Stretta proced-
ure, which was significantly reduced at 6 months after the
Stretta procedure and the reduction sustained at 24, 38
and 48 months (data not shown). By the end of the 5-year
follow-up, the total heartburn score was significantly
lower as compared with the score before the Stretta pro-
cedure (P < 0.001) and the effect of the procedure was of
no significant difference in patients with and without
extraesophageal symptoms (P > 0.05, Figure 1). Eighty-
two (59.4%) patients reported regurgitation, 29 (21%)
chest pain, 75 (54.3%) cough and 57 (41.3%) asthma. Theaverage total symptom score before treatment was 5.56 ±
1.65 for regurgitation, 4.79 ± 1.59 for chest pain, 6.62 ± 1.73
for GERD-related cough and 6.83 ± 1.46 for GERD-related
asthma. In a pattern exactly the same as that for heartburn,
the total symptom scores for regurgitation (Figure 2), chest
pain
(Figure 3), cough (Figure 4) and asthma (Figure 5)
were all significantly reduced after the Stretta procedure
(P < 0.001).
With regard to the secondary outcome measures, 38
(27.5%) of the 138 patients were completely off PPIs at
6 months following the Stretta procedure. By 60 months,
59 (42.8%) patients were completely off PPIs (Figure 6).
In the 46 patients who were using PPIs as needed com-
plained of extraesophageal symptoms before treatment.
Medication was completely eliminated in 74.5% of the
patients without extraesophageal symptoms at 60 months.
Out of the 138 patients, 104 (75.4%) patients were fully or
partially satisfied with the treatment and 94 (69.6%)
expressed willingness to do the procedure again if neces-
sary. In the 34 (24.6%) patients who were not satisfied with
the treatment, 26 would definitely not undergo the proced-
ure again.
During the 5-year follow-up, no post procedure perfora-
tions, mucosal laceration, bleeding episodes requiring
transfusion, or deaths were observed. After the procedure,
12 patients complained of abdominal distention, which
was moderately alleviated after treatment with trimebutine
maleate tablets in combination with lifestyle modifications.
Discussion
GERD significantly impairs the quality of life of the af-
fected individuals. The current management strategies in-
clude lifestyle modifications, pharmacological therapies,
surgical fundoplication, and, more recently, endoscopic
procedures [9,14]. An ideal GERD management modality
should be able to effectively control symptoms, heal the
injured oesophageal mucosa, and prevent complications
in a convenient and inexpensive fashion. Both PPI-based
pharmacological and surgical therapies fail to fall into the
“ideal” treatment category PPI therapy is associated with a
high refraction rate, troublesome daily administration and
significant adverse effects while surgical fundoplication
involves invasiveness and is associated with high cost and
high risks of postoperative complications. Recently, the
minimally invasive Stretta procedure has become an
acceptable option for patients who are PPI-refractory and
poor surgical candidates yet still require intensive treat-
ment to adequately manage their GERD. Nevertheless, the
long-term benefits of this minimally invasive procedure
need to be further evaluated.
In this prospective study, we followed up 138 adult
patients with PPI-refractory GERD for 5 years after the
Stretta procedure. Our results clearly demonstrated that
Figure 1 Total heartburn score (frequency score + severity score) in 94 patients with or without extraesophageal symptoms
before the Stretta procedure and at the 5-year follow-up. A single asterisk (*) denotes a significant difference between bars in the same
cluster (P < 0.001).
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and severity of GERD-associated symptoms (Figures 1, 2,
3, 4 and 5) including heartburn, regurgitation, chest pain,
cough and asthma. The effect was evident at 6 months
after the procedure and sustained over the entire observa-
tional period of 5 years. In the current literature, numerous
studies have evaluated the efficacy of the Stretta procedure
in the management of medication-refractory GERD
[17,22,23,25,26], but few studies have followed up the pa-
tients for more than 4 years. Our long-term observations
support the claim that the endoluminal Stretta procedure
is an effective modality of symptom control in selected
GERD patients [2].
In addition to the primary outcome measures discussed
above, we also assessed the medication elimination post-Figure 2 Total regurgitation score (frequency score + severity score) i
before the Stretta procedure and at the 5-year follow-up. A single aste
cluster (P < 0.001).treatment, the treatment-associated complications and
patient satisfaction of the treatment. Prior to the Stretta
procedure, 100% patients enrolled in the study used PPI.
After the procedure, the medication elimination rate
increased with time, from 27.5% at 6 months to 42.8% at
5 years (Figure 6). In two previous studies, complete PPI
elimination was achieved in 75% and 86.4% of the GERD
patients at 48 months after the Stretta procedure respect-
ively [20,21], which was slightly higher than the rate
observed in our study. The discrepancy might be partially
a result of differences in the quality of the drugs from
different manufacturers. Nevertheless, this needs to be fur-
ther determined in comparative studies in the future. Out
of the 138 patients, 75.4% were partially or fully satisfied
with the Stretta radiofrequency treatment. This satisfactionn 82 patients with or without extraesophageal symptoms
risk (*) denotes a significant difference between bars in the same
Figure 3 Total chest pain score (frequency score + severity
score) in 29 patients at the indicated time points. A single
asterisk (*) denotes a significant difference between bars in the
same cluster (P < 0.001).
Figure 5 Total GERD-related asthma score (frequency score +
severity score) in 57 patients at the indicated time points. A
single asterisk (*) denotes a significant difference between bars in
the same cluster (P < 0.001).
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where 77.0% of 558 patients from 33 institutions with a
mean follow-up period of 8 months were satisfied with the
Stretta procedure) [27]. In this study, no significant post-
procedure complications were observed except for abdom-
inal distention in 12 (8.7%) patients, supporting previous
results on the safety of the Stretta procedure [20,23].
Extraesophageal symptoms such as cough and throat
clearing are not commonly associated with GERD [28].
However, the vast majority of the patients assessed in this
study reported extraesophageal symptoms. Different from
previous studies [20,22,25,29], we performed stratified
analyses of heartburn, regurgitation and PPI elimination
based on the presence or absence of extraesophageal
manifestations.Figure 4 Total GERD-related cough score (frequency score +
severity score) in 75 patients at the indicated time points.
A single asterisk (*) denotes a significant difference between bars in
the same cluster (P < 0.001).We found that the Stretta procedure was effective to
control heartburn and regurgitation very similarly in
GERD patients with and without extraesophageal symp-
toms (Figures 1 and 2) but was less effective in eliminating
PPI usage in patients with extraesophageal symptoms than
in patients without extraesophageal symptoms (Figure 6).
To our knowledge, little is known in the current literature
regarding the efficacy of the Stretta procedure in GERD
patients with and without extrasophageal symptoms,
which warrants further investigations.
The mechanism underlying the therapeutic effect of the
Stretta procedure remains to be further elucidated. It has
been documented that endoluminal radiofrequency energy
delivery to the gastroesophageal junction causes local in-
flammation, subsequent collagen deposition and muscularFigure 6 Changes in the proportion of patients with (n = 87)
and without (n = 51) extraesophageal symptoms who were
independent of PPI therapy at the indicated time points.
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stomach [30,31]. Alternatively, the Stretta procedure may
achieve its clinical benefits through increasing the intragas-
tric pressure needed to induce reflux and improve the gas-
tric emptying [32-34] and/or decreasing compliance of the
gastro-esophageal junction [17]. Moreover, the Stretta pro-
cedure may also exert its effect through the involvement of
the vagal nerve, which remains controversial [9,35].
Conclusions
In summary, through prospective observation for 5 years,
we demonstrated that the Stretta procedure was capable
of controlling GERD symptoms effectively and safely.
While a slight difference in the complete PPI elimination
after the Stretta procedure was observed between GERD
medication-refractory patients with and without extraeso-
phageal manifestations, the effect of the procedure on
changes in heartburn, regurgitation, chest pain, cough and
asthma was not associated with extraesophageal manifes-
tations. Our observations suggest that the Stretta proced-
ure should be considered as a reliable treatment modality
for adult patients with medication-refractory GERD.
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